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ABSTRACT 
The DREZotomy (Dorsal Root Entry Zone tomy) is an analgesic procedure. The 
analgesic effect is evaluated on 30 patients with chronic pain resulting from 
respectively: brachial plexus avulsion (66.6%), postherpetic pain (10%), hyperspastic 
states (6.6%), phantom pain (6.6%), the pain in the stump (6.6%), and spinal cord 
injuries (3.3%). Pain intensity was evaluated using a visual analogue scale (VAS). At last 
evaluation, between 12 and 60 months, after DREZotomy, 93% had a good or 
excellent global pain relief after surgery. According to the component types of pain, 
9.6% of patients had good or excellent control of the paroxysmal pain, and 84% of 
the continuous pain. Kaplan–Meier prediction of lasting global pain control at 60 
months of follow-up was calculated at 75.5%. Comparison of the 2 corresponding 
Kaplan–Meier curves at long term, namely, pain control in 82.8% for the paroxysmal 
component and in 51.7% for the continuous component, showed a statistically 
significant difference (P < 0.0001). Functional effects are improved by more than 70% 
according to patients. 
 
 
 
INTRODUCTION 
Chronic pain is a major public health problem, causing disability and of 
considerable human suffering. Depressive states are frequently 
associated with it; without counting the health costs it generates. There 
are, however, situations where conservative methods such as 
conventional drugs and psychotherapies are not effective and where 
the use of "lesional" neurosurgical management can provide an 
effective solution. This is the case for certain microsurgical techniques 
including DREZotomy (DREZ: Dorsal Root Entry Zone). This technique 
consists in interrupting the so-called nociceptive fibers and destroying 
by coagulation the hyperactive neurons located in the dorsal horn, 
corresponding to the area of pain, respecting the other fibers. It has 
been shown to be effective in some cases of chronic pain [2-5, 8, 9]. 
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METHODS 
We conducted a prospective study of 30 patients 
who underwent microsurgical DREZotomy for 
chronic pain resistant to medical treatment. This 
work was carried out between July 2007 and January 
2015. Our series included 2 women and 28 men, who 
had an average age of 46 years with extreme ages of 
25 and 79 years. All patients had a detailed clinical 
assessment including the characteristics of their 
pain, its intensity using the Visual Analog Scale (VAS), 
as well as an assessment of the psychological impact 
of the pain. Imaging, represented by CT scan and / or 
spinal MRI, was performed before the surgery to 
assess the extent of the lesions. 
 
ETIOLOGIES 
The chronic pain that affected our patients was 
caused by sequelae of brachial plexus avulsion (BPA) 
in 20 cases (66.6%) (figure 1), postherpetic neuralgia 
in 3 cases (10%), stump pain in 2 cases ( 6.6%), the 
phantom limb in 2 cases (6.6%), spasticity in 2 cases 
(6.6%) and one case (3.3%) of spinal cord injury. 
 
PAIN DESCRIPTION 
In our study, more than half of the patients (56.7%) 
experienced pain initially, and 33.3% two months 
after the onset of the lesions. The time between 
onset of pain and surgery is on average 5 ± 1 year. 
Three patients had a DN4 (Douleur Neuropathique 
en 4 Questions, French for neuropathic pain in 4 
questions), lower than 3, including 2 with stump pain 
and one patient with phantom limb pain. In fact, 
during the interrogation, we noted in 25 patients 
(83.3%) the presence of tingling. These latter involved 
18 patients with BPA (90%), all patients with 
postherpetic neuralgia, spinal cord injury and a 
patient with phantom limb pain (50%). Numbness 
was reported in 3 patients (10%) including two 
patients with BPA (10%) and a patient with spasticity 
(50%). Dysesthesia was present in one patient who 
has BPA. Analogous visual scale (VAS) of our patients 
was initially on average 9.20 ± 1.06 with extreme 
values of 7 and 10. Two categories of pain were 
noted, in particular electrical shooting-like 
paroxysmal pain, and the continuous pain realizing a 
painful background most often a burning type. The 
two components combined were present in 83% of 
patients. The paroxysmal and background 
components alone interested 6.7% and 10% of the 
patients, respectively. In the BPA, the pain concerned 
C6 and C7 dermatomes in all cases, and C8 and T1 
dermatomes, in 95% and 90% of cases, respectively. 
For stump pain, the dermatomes affected by the 
pain range from C6 to T1. For the phantom limb, the 
pain areas extend from C5 to T1. In the three patients 
with postherpetic neuralgia, the dermatomes 
concerned range from C7 to T1 and from T3 to T8 at 
a frequency of 33.33% of cases for each one, 
associated in cases with allodynia. In the patient who 
suffered from chronic pain due to spinal cord injury, 
the dermatomes involved range from L2 to S2. As for 
patients suffering from spastic pain, the 
dermatomes concerned are L1 and L2 but also L4, L5 
and S1. Whatever the causal etiology of chronic pain, 
there is a noticeable impact on several aspects of life, 
whether individual, social or professional.  
 
MEDICAL TREATMENT 
All of our patients received simultaneous treatment 
with WHO class I and II anticonvulsants, tricyclics and 
analgesics. However, we note that 5 (16.6%) of our 
patients took at least occasional WHO class III 
analgesics during their previous management. Two 
of our three patients with postherpetic neuralgia 
used topical lidocaine as a patch in the allodynic 
areas. Although the duration of treatment was 5 
years ± 1 year, there was no reported improvement. 
 
SURGICAL MANAGEMENT 
Microsurgical DREZotomy was performed under 
general anesthesia. The patients were placed in the 
prone position. The laminectomy was homolateral to 
the corresponding painful dermatomes and bilateral 
when the symptomatology concerned both sides. 
After opening the dura mater, micro-incisions under 
an operating microscope were performed at the 
spinal cord dorsolateral sulcus at the entrance of the 
posterior roots. The incision was of 2 mm deep at an 
angle of 35 ° anteriorly and medially when it was the 
cervical and thoracic levels and 45 ° when it was the 
lumbar region. These incisions were followed by low-
intensity micro-coagulations (figures 2 and 3). 
 
RESULTS 
The effects of DREZotomy on pain are evaluated 
when the patient is discharged from the hospital, in 
average, 15 days after surgery, but also evaluated at 
3 months and at long term (beyond 6 months). 
Whatever the etiology, the results of DREZotomy are 
mainly excellent for 26 patients (86.6%) at discharge, 
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for 25 patients (86.2%) at 3 months, and for 20 
patients (68.9%) in the long term; the good results 
interested 4 patients (13.3%) at discharge, 4 patients 
(13.7%) at 3 months and 7 patients (24.1%) in the 
long term; poor results are rare and concerned only 
2 patients (6.8%) in the long term (Figure 4). The long-
term overall pain control defined by excellent to 
good results is studied by the KAPLAN-MEIER curve; 
this one shows 75.7% pain control over a 60 month 
follow-up period (Figure 5). In our study, the results 
are excellent on allodynia, especially in patients with 
postherpetic neuralgia. The correlation between the 
number of painful dermatomes and the results of 
microsurgical DREZotomy is statistically significant; 
the fewer the number of dermatomes, the more 
excellent the results of the DREZotomy (p = 0.0093). 
The control of the pain components defined by 
excellent and good results is analyzed using the 
KAPLAN-MEIER curve; this one shows that the control 
of the paroxysmal and continuous components is 
estimated respectively at 82.8% and 51.7% over a 
period of 60 months (Figures 6 and 7). This analysis 
demonstrates the effectiveness of the technique on 
the various components of pain with a predilection 
on the paroxysmal component compared to the 
continuous component (p <0.0001). Surgical 
DREZotomy improves the quality of life in all its 
aspects and whatever the etiology. This 
improvement is statistically significant in all cases (p 
= 0.00000). There is an average improvement of 83 ± 
15% in daily activity, 79 ± 14% in walking, 85 ± 14% in 
the mood, 77 ± 15% in social relationships, and 85 ± 
14% in sleep quality. The reduction in the doses of 
the drugs was performed gradually until stopping, in 
3-4 weeks. Analgesic treatment at low doses was 
continued in 6 patients. Complications are generally 
few and quickly resolve; limited essentially to neck 
pain in 15.4% of cases, and in much rarer cases there 
was: CSF fistula in 3.3% of cases, ataxia, tactile 
hypoesthesia, transient or permanent 
arthrokinesthesia, transient dysthesia, and mild 
motor disorder in 3.7% of cases for each of these 
complications. We regret a death of one patient 
which occurred during hospitalization caused by a 
pulmonary embolism. 
 
 
Figure 1. Preoperative cervical spine MRI in T2 weighted images, in patient suffering from brachial plexus avulsion pain; A: axial 
slide, B: coronal slide, C: sagittal slide; the arrow shows a pseudoméningocèle characteristic lesion of brachial plexus avulsion. 
 
 
 
Figure 2. Per operative pictures in patient suffering from brachial plexus avulsion; A: before DREZotomy, B: after DREZotomy. The 
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black arrows show the DREZotomy zone for an avulsed C6 root, the white arrows show micro blood vessels entering the DREZ zone, 
the full star shows the C5 root, the empty star shows the spinal cord, and the ring the denticulate ligaments. 
 
 
 
Figure 3. Per operative pictures in a patient suffering from postherpetic neuralgia; A: before DREZotomy, B: after DREZotomy. The 
black arrows show the DREZotomy zone, the white arrows show atrophied C7 root. 
 
 
Figure 4. Good to excellent results of DREZotomy on overall 
pain at discharge, at 3 months and in the long term, all 
etiologies taken together (Excellent: Improvement greater than 
75%; good: Improvement between 75% and 50%, and poor 
improvement less than 50%). 
 
 
 
Figure 5. Kaplan Meier curve describing in percentage the long-
term overall pain control (excellent to good). Pain control is 
estimated at 75.7% over a 60-month follow-up period. 
Excellent: Improvement greater than 75%; Good: Improvement 
between 75% and 50%. 
 
 
 
Figure 6. The Kaplan Meier curve describing in percentage the 
control of the paroxysmal component of pain (excellent to 
good) in the long term. Pain control is estimated at 82.8% over 
a period of 60 months. Excellent: Improvement greater than 
75%; Good: Improvement between 75% and 50%. 
 
 
 
Figure 7. The Kaplan Meier curve describing in percentage the 
control of the continuous component of pain (excellent to 
good) in the long term. Pain control is estimated at 51.7% over 
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a period of 60 months. Excellent: Improvement greater than 
75%; Good: Improvement between 75% and 50%. 
 
DISCUSSION 
We believe that the effectiveness of DREZotomy on 
pain reinforces the hypothesis that the dorsal horn 
plays a main role in the genesis of pain [4]. Guenot et 
al report the appearance of hyperactive neurons 
after the experimental rhizotomy performed in 
animals [13]. DREZotomy significantly suppresses 
autotomy behavior in animals that have undergone 
rhizotomy. Neuron hyperactivity has also been 
recorded using microelectrodes implanted in the 
dorsal horn during the DREZotomy procedure for 
BPA pain [12, 14, 16]. The fact that the paroxysmal 
component is often reduced by DREZotomy, 
suggests that its origin predominates in the dorsal 
horn. Central sensibilisation by the phenomenon of 
denervation cannot in itself explain the mechanism 
generating pain within the dorsal horn. Like other 
authors, we have frequently observed 
intraoperatively, the presence of hemosiderin 
deposits, microcavitations and gliotic tissue within 
the gray matter of the dorsal horn in the cases of BPA 
and spinal cord injury [4,10,17]. These lesions can 
cause a change in normal activity within this region 
and consequently cause dysfunction of the pain 
pathways at the spinal or cerebral level [16]. 
However, it is quite clear that not all pain-generating 
centers are located at the dorsal horn. As for the 
mechanism of the continuous component, 
dominated by the burning sensation which is less 
influenced by DREZotomy than the paroxysmal 
component, it remains less clear; however, several 
hypotheses can be put forward. BPA causes more or 
less extensive necrosis of cells belonging to the 
dorsal horn that participate in the spinothalamic 
tract ascending pathway, as well as in the case of 
spinal cord trauma. This results in some degree of 
spino-reticulo-thalamic pain responsible of the 
continuous component [4]. The mechanisms of 
postherpetic neuralgia are similar to the above-
mentioned mechanisms; the presence of the 
varicella zoster virus in the sensory neurons of the 
dorsal ganglion [1] causes inflammation and cell 
destruction within it [7,15, 23]. The inflammatory 
process extends along the sensitive fibers to the 
dorsal horn, causing lesions similar to those 
observed in the BPA [3], which explains the beneficial 
effect of DREZotomy on the two components, in 
particular the component paroxysmal as well as 
allodynia. DREZotomy acts by suppressing the 
collaterals of the Aβ fibers which are oriented 
towards the nociceptive layers of the dorsal horn. 
Several hypotheses are suggested in the stump pain 
and the phantom limb pain. In fact, the loss of the 
afferent influx from the periphery leads to irritation 
of the neurons of the dorsal horn and their 
hyperexcitability and reduction of inhibitory 
processes [11,18, 25]. This gives the DREZ area a 
therapeutic interest. According to the series, 
paraplegic pain is mostly secondary to the conus 
medullaris lesion which often accompanies spinal 
trauma [21], probably in relation with the site 
corresponding to the thoraco-lumbar junction which 
is exposed to frequently to fractures. The thoraco-
lumbar junction corresponds to numerous spinal 
segments condensed on a small poorly vascularized 
(Adamkiewicz artery) explaining their concomitant 
involvement during the trauma. The mechanism of 
spastic pain may be linked to painful spasms, painful 
contracture and neuropathic pain [21]; which occurs 
in multiple sclerosis [8,9], and spinal cord injury [10]. 
This neuropathic disorder is secondary to a 
demyelization of the spino-thalamic tract [6,24] and 
the posterior horn where the paroxysmal and 
continuous components are usually present. The 
beneficial effect of DREZotomy, on the various 
components of pain in particular the paroxysmal 
component was obtained by interrupting the 
myotatic fibers (monosynaptics), and the nociceptive 
fibers (polysynaptics), thus depriving the 
somatosensitive relays of the dorsal horn of all 
excitatory afferents [22]. 
 
CONCLUSIONS 
DREZotomy has a satisfactory operating risk / benefit 
ratio with few side effects. It is suitable for chronic 
refractory pain especially BPA and spinal cord injury. 
It significantly attenuates chronic pain in its 
paroxysmal but also continuous components with 
supremacy for paroxysmal pain, including in 
allodynic phenomena. 
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